Clinical Publications

  • Peter Barlis, et al. An optical coherence tomography study of biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study. European Heart Journal (2010) 31, 165-176.
  • Garg S, et al. The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer. EuroIntervention 2010; 6: 233-239
  • Wykrzykowska JJ, et al. Value of the Syntax score for the risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus Erodable Stent coating) trial. J Am Coll Cardiol. 2010;56:272-277.
  • Sarno G., et al. The Impact of Body Mass Index on the One Year Outcomes of Patients Treated by Percutaneous Coronary Intervention With Biolimus- and Sirolimus-Eluting Stents (from the LEADERS Trial). Am J Cardiol 2010;105:475– 479.
  • Schmidt, Wolfram et al; A comparison of the mechanical performance characteristics of seven drug-eluting stent systems; Catheterization and Cardiovascular Interventions, 2009; 73 350-360
  • Windecker, Stephan et al. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. The Lancet 2008; 372: 1163-73.
  • Grube, E., Buellesfeld, L. BioMatrix biolimus-eluting coronary stent: A next-generation drug-eluting stent for coronary artery disease. Expert Rev Med Devices 2006; 3(6): 731-41.